Rapporto sull’analisi delle dimensioni del mercato dei farmaci anti-coagulanti e dell’analisi delle quote | Previsioni 2031

  • Report Code : TIPRE00004954
  • Category : Pharmaceuticals
  • Status : Data Released
  • No. of Pages : 150
Buy Now

Si prevede che la dimensione del mercato dei farmaci anticoagulanti raggiungerà i 2.442,87 milioni di dollari entro il 2031 dai 1.306,40 milioni di dollari del 2023. Si prevede che il mercato registrerà un CAGR del 10,08% nel 2023-2031.

I segmenti chiave che hanno contribuito alla derivazione dell'analisi di mercato dei farmaci anticoagulanti sono il prodotto e il canale di distribuzione.

  • Sulla base del prodotto, il mercato dell'inversione degli anticoagulanti è suddiviso in protrombina concentrati complessi, vitamina K, protamina, acido tranexamico, idarucizumab e AndeXXa. Il segmento dei concentrati del complesso protrombinico ha detenuto la quota maggiore del mercato nel 2023.
  • In termini di canale di distribuzione, il Il mercato dei farmaci antivirali anticoagulanti è segmentato in farmacie ospedaliere, farmacie al dettaglio e altri. Il segmento delle farmacie ospedaliere ha detenuto la quota maggiore del mercato nel 2023.

Analisi della quota di mercato dei farmaci ad inversione anticoagulante per area geografica

L'ambito geografico del rapporto sul mercato dei farmaci antivirali anticoagulanti è suddiviso principalmente in cinque regioni: Nord America, Asia Pacifico, Europa, Medio Oriente e Stati Uniti. Africa e Sud & America Centrale.

Il Nord America ha dominato il mercato dei farmaci antivirali anticoagulanti. Nel Nord America, gli Stati Uniti rappresentano il mercato più grande per i farmaci antagulanti. La crescita di questo mercato è guidata principalmente dalla crescente prevalenza di malattie cardiovascolari come la fibrillazione atriale, dagli sviluppi degli operatori del mercato e la presenza dei principali operatori del mercato negli Stati Uniti accelererà la crescita di questo mercato in questo paese. Inoltre, è probabile che gli sviluppi strategici degli operatori del mercato negli Stati Uniti favoriscano la crescita del mercato. Ad esempio, nel giugno 2023, AstraZeneca ha proceduto con la documentazione normativa completa per il suo Andexxa (andexanet alfa) negli Stati Uniti e nell’UE, andando avanti rispetto all’attuale approvazione condizionale. Andexxa è un trattamento che può invertire rapidamente gli effetti anticoagulanti degli inibitori orali diretti di FXa. Oltre 15 linee guida nazionali e internazionali in più discipline ne supportano l’utilizzo. AstraZeneca ha ora proceduto con le richieste normative per l'approvazione completa dell'etichetta negli Stati Uniti.

Ambito del rapporto sul mercato dei farmaci ad inversione anticoagulante

Mercato dei farmaci ad inversione anticoagulante span> Notizie e sviluppi recenti

Il mercato dei farmaci per l'inversione degli anticoagulanti viene valutato raccogliendo dati qualitativi e quantitativi dalla ricerca primaria e secondaria, che comprende importanti pubblicazioni aziendali, dati di associazioni e database. Di seguito è riportato un elenco degli sviluppi nel mercato dei disturbi della parola e del linguaggio e delle strategie:

  • AstraZeneca Pharma India Ltd. ha annunciato di aver ricevuto l'approvazione da la Central Drugs Standard Control Organization (CDSCO) in India per importare e commercializzare Andexanet Alfa. Questo trattamento è efficace nel trattare i sanguinamenti potenzialmente letali o refrattari che derivano dall’uso degli inibitori del fattore Xa (FXa). (Fonte: AstraZeneca Pharma, comunicato stampa, 2024)
  • Octapharma USA ha annunciato l'approvazione di Balfaxar da parte della Food and Drug Administration (FDA) statunitense. Balfaxar è un concentrato di complesso protrombinico a quattro fattori non attivato (4F-PCC) contenente fattori dipendenti dalla vitamina K: Fattore II (protrombina), Fattore VII, Fattore IX e Fattore X, e proteine antitrombotiche C e S. Può essere utilizzato per invertire urgentemente il deficit acquisito dei fattori della coagulazione indotto dalla terapia con antagonisti della vitamina K (AVK) in pazienti adulti che necessitano di un intervento chirurgico urgente o di procedure invasive. Balfaxar aiuta a ripristinare la coagulazione del sangue reintegrando i livelli di fattori della coagulazione carenti a causa della terapia con warfarin. (Fonte: Octapharma USA, Inc, comunicato stampa, 2023)

Copertura e risultati del rapporto sul mercato dei farmaci ad inversione anticoagulante

Il “Mercato dei farmaci con inversione anticoagulante Dimensioni e previsioni (2021-2031)” il rapporto fornisce un'analisi dettagliata del mercato che copre le aree seguenti:

  • Dimensioni e previsioni del mercato a livello globale, regionale e nazionale per tutti i segmenti di mercato chiave coperti dal ambito
  • Dinamiche di mercato come fattori trainanti, restrizioni e opportunità chiave
  • Principali tendenze future
  • PEST/Porter’ s Le cinque forze e analisi SWOT
  • Analisi del mercato globale e regionale che copre le principali tendenze del mercato, i principali attori, le normative e i recenti sviluppi del mercato
  • Panorama industriale e analisi della concorrenza che copre la concentrazione del mercato, l'analisi della mappa termica, gli attori principali e gli sviluppi recenti
  • Profili aziendali dettagliati
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports